Literature DB >> 25512803

Flavonoid-rich beverage effects on lipid profile and blood pressure in diabetic patients.

Reza Amani1, Sara Moazen1, Hajieh Shahbazian1, Kambiz Ahmadi1, Mohammad Taha Jalali1.   

Abstract

AIM: To compare freeze-dried strawberry (FDS) beverage and strawberry-flavored drink effects on lipid profile and blood pressure in type 2 diabetic (T2D) patients.
METHODS: In a randomized, double-blind, controlled trial, 36 subjects with T2D (23 females; mean ± SE age: 51.57 ± 10 years) were randomly divided into two groups. Participants consumed two cups of either pure FDS beverage (each cup containing 25 g freeze-dried strawberry powder equivalent to one serving of fresh strawberries; intervention group) or an iso-caloric drink with strawberry flavoring (similar to the FDS drink in fiber content and color; placebo group) daily for 6 wk. Anthropometric measurements, 3 d, 24 h dietary recall, and fasting blood samples were collected at baseline and at weeks 6 intervention. After lying down and relaxing for approximately 10 min, each participant's blood pressure was recorded in triplicate with 5 min intervals; recordings were made at baseline and the trial end-point. Each participant's lipid profile was assessed before and after intervention.
RESULTS: Assessment at the weeks 6 intervention showed a significant reduction from baseline in total cholesterol levels and total cholesterol to high-density lipoprotein cholesterol (HDL-C) ratio in the intervention group (179.01 ± 31.86 to 165.9 ± 32.4 mg/L; P = 0.00 and 3.9 ± 0.88 to 3.6 ± 0.082 mg/L; P = 0.00 respectively), but the change was not significantly different between the two groups (P = 0.07, P = 0.29 respectively). Systolic blood pressure levels were significantly reduced from baseline in both the FDS and placebo drink groups (129.95 ± 14.9 to 114.3 ± 27.5 mmHg; P = 0.02 and 127.6 ± 15.6 to 122.9 ± 14.47 mmHg; P = 0.00 respectively), but the reduction was not significantly different between the two groups. Diastolic blood pressure was significantly reduced post-intervention in the FDS drink group compared to placebo group (78.7 ± 7.2 vs 84.4 ± 5.8; P = 0.01), the reduction was also significant within the FDS drink group (84.2 ± 8.03 to 78.7 ± 7.2; P = 0.00). Triglycerides, HDL-C concentrations and anthropometric indices showed no significant differences between or within groups.
CONCLUSION: Short-term FDS supplementation improved selected cardiovascular risk factors in subjects with T2D. Long-term effects on other metabolic biomarkers need to be investigated in future trials.

Entities:  

Keywords:  Blood pressure; Flavonoid rich beverage; Lipid profile; Type 2 diabetes

Year:  2014        PMID: 25512803      PMCID: PMC4265887          DOI: 10.4239/wjd.v5.i6.962

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  22 in total

1.  Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing.

Authors:  M I Gil; F A Tomás-Barberán; B Hess-Pierce; D M Holcroft; A A Kader
Journal:  J Agric Food Chem       Date:  2000-10       Impact factor: 5.279

2.  The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes.

Authors:  D J A Jenkins; K Srichaikul; C W C Kendall; J L Sievenpiper; S Abdulnour; A Mirrahimi; C Meneses; S Nishi; X He; S Lee; Y T So; A Esfahani; S Mitchell; T L Parker; E Vidgen; R G Josse; L A Leiter
Journal:  Diabetologia       Date:  2010-10-27       Impact factor: 10.122

3.  Anti-diabetic properties of the Canadian lowbush blueberry Vaccinium angustifolium Ait.

Authors:  Louis C Martineau; Audrey Couture; Danielle Spoor; Ali Benhaddou-Andaloussi; Cory Harris; Bouchra Meddah; Charles Leduc; Andrew Burt; Tri Vuong; Phuong Mai Le; Marc Prentki; Steffany A Bennett; John T Arnason; Pierre S Haddad
Journal:  Phytomedicine       Date:  2006-09-18       Impact factor: 5.340

Review 4.  Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus.

Authors:  L Heilbronn; S R Smith; E Ravussin
Journal:  Int J Obes Relat Metab Disord       Date:  2004-12

5.  Anthocyanidins decrease endothelin-1 production and increase endothelial nitric oxide synthase in human endothelial cells.

Authors:  Maria Claudia Lazzè; Roberto Pizzala; Paola Perucca; Ornella Cazzalini; Monica Savio; Luca Forti; Vanio Vannini; Livia Bianchi
Journal:  Mol Nutr Food Res       Date:  2006-01       Impact factor: 5.914

6.  Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome.

Authors:  Arpita Basu; Mei Du; Misti J Leyva; Karah Sanchez; Nancy M Betts; Mingyuan Wu; Christopher E Aston; Timothy J Lyons
Journal:  J Nutr       Date:  2010-07-21       Impact factor: 4.798

7.  Vascular reactivity is affected by dietary consumption of wild blueberries in the Sprague-Dawley rat.

Authors:  Anastasia Z Kalea; Kateryna Clark; Dale A Schuschke; Dorothy J Klimis-Zacas
Journal:  J Med Food       Date:  2009-02       Impact factor: 2.786

8.  Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects.

Authors:  Yu Qin; Min Xia; Jing Ma; YuanTao Hao; Jing Liu; HaiYing Mou; Li Cao; WenHua Ling
Journal:  Am J Clin Nutr       Date:  2009-07-29       Impact factor: 7.045

9.  The effect of strawberries in a cholesterol-lowering dietary portfolio.

Authors:  David J A Jenkins; Tri H Nguyen; Cyril W C Kendall; Dorothea A Faulkner; Balachandran Bashyam; In Joo Kim; Chris Ireland; Darshna Patel; Edward Vidgen; Andrea R Josse; Howard D Sesso; Britt Burton-Freeman; Robert G Josse; Lawrence A Leiter; William Singer
Journal:  Metabolism       Date:  2008-12       Impact factor: 8.694

10.  Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol.

Authors:  Iris Erlund; Raika Koli; Georg Alfthan; Jukka Marniemi; Pauli Puukka; Pirjo Mustonen; Pirjo Mattila; Antti Jula
Journal:  Am J Clin Nutr       Date:  2008-02       Impact factor: 7.045

View more
  7 in total

1.  Pelargonidin 3-glucoside-enriched strawberry attenuates symptoms of DSS-induced inflammatory bowel disease and diet-induced metabolic syndrome in rats.

Authors:  Naga Kr Ghattamaneni; Ashwini Sharma; Sunil K Panchal; Lindsay Brown
Journal:  Eur J Nutr       Date:  2019-11-07       Impact factor: 5.614

Review 2.  Select Polyphenol-Rich Berry Consumption to Defer or Deter Diabetes and Diabetes-Related Complications.

Authors:  Ahsan Hameed; Mauro Galli; Edyta Adamska-Patruno; Adam Krętowski; Michal Ciborowski
Journal:  Nutrients       Date:  2020-08-21       Impact factor: 5.717

Review 3.  Chemical Compounds of Berry-Derived Polyphenols and Their Effects on Gut Microbiota, Inflammation, and Cancer.

Authors:  Abdelhakim Bouyahya; Nasreddine El Omari; Naoufal El Hachlafi; Meryem El Jemly; Maryam Hakkour; Abdelaali Balahbib; Naoual El Menyiy; Saad Bakrim; Hanae Naceiri Mrabti; Aya Khouchlaa; Mohamad Fawzi Mahomoodally; Michelina Catauro; Domenico Montesano; Gokhan Zengin
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

Review 4.  The Role of Berry Consumption on Blood Pressure Regulation and Hypertension: An Overview of the Clinical Evidence.

Authors:  Stefano Vendrame; Tolu Esther Adekeye; Dorothy Klimis-Zacas
Journal:  Nutrients       Date:  2022-06-29       Impact factor: 6.706

Review 5.  Berry Fruit Consumption and Metabolic Syndrome.

Authors:  Stefano Vendrame; Cristian Del Bo'; Salvatore Ciappellano; Patrizia Riso; Dorothy Klimis-Zacas
Journal:  Antioxidants (Basel)       Date:  2016-09-30

6.  Effects of Anthocyanin-rich Berries on the Risk of Metabolic Syndrome: A Systematic Review and Meta-analysis.

Authors:  Mikkel Roulund Wilken; Max Norman Tandrup Lambert; Christine Bodelund Christensen; Per Bendix Jeppesen
Journal:  Rev Diabet Stud       Date:  2022-03-09

Review 7.  Bioactive Plant Metabolites in the Management of Non-Communicable Metabolic Diseases: Looking at Opportunities beyond the Horizon.

Authors:  Chandan Prasad; Victorine Imrhan; Shanil Juma; Mindy Maziarz; Anand Prasad; Casey Tiernan; Parakat Vijayagopal
Journal:  Metabolites       Date:  2015-12-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.